Placebo and nocebo effects
L Colloca, AJ Barsky - New England Journal of Medicine, 2020 - Mass Medical Soc
Placebo and Nocebo Effects Placebo and nocebo effects (effects of patients' positive and
negative expectations) are powerful and pervasive in clinical practice. Neurobiologic …
negative expectations) are powerful and pervasive in clinical practice. Neurobiologic …
Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice
TJ Kaptchuk, CC Hemond, FG Miller - bmj, 2020 - bmj.com
Despite their ubiquitous presence, placebos and placebo effects retain an ambiguous and
unsettling presence in biomedicine. Specifically focused on chronic pain, this review …
unsettling presence in biomedicine. Specifically focused on chronic pain, this review …
The alliance in mental health care: conceptualization, evidence and clinical applications
BE Wampold, C Flückiger - World Psychiatry, 2023 - Wiley Online Library
The concept of alliance reflects the collaborative relationship between a clinician and a
patient, defined as consisting of three elements: a) the agreement on the goals of treatment; …
patient, defined as consisting of three elements: a) the agreement on the goals of treatment; …
Eptinezumab in episodic migraine: a randomized, double-blind, placebo-controlled study (PROMISE-1)
M Ashina, J Saper, R Cady, BA Schaeffler… - …, 2020 - journals.sagepub.com
Objective To evaluate the efficacy and safety of eptinezumab, a humanized anti-calcitonin
gene-related peptide monoclonal antibody, in the preventive treatment of episodic migraine …
gene-related peptide monoclonal antibody, in the preventive treatment of episodic migraine …
Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2
RB Lipton, PJ Goadsby, J Smith, BA Schaeffler… - Neurology, 2020 - AAN Enterprises
Objective To evaluate the efficacy and safety of eptinezumab, a humanized anti–calcitonin
gene-related peptide monoclonal antibody, in the preventive treatment of chronic migraine …
gene-related peptide monoclonal antibody, in the preventive treatment of chronic migraine …
The neuroscience of placebo effects: connecting context, learning and health
Placebo effects are beneficial effects that are attributable to the brain–mind responses to the
context in which a treatment is delivered rather than to the specific actions of the drug. They …
context in which a treatment is delivered rather than to the specific actions of the drug. They …
Effects of open-label placebos in clinical trials: a systematic review and meta-analysis
M von Wernsdorff, M Loef, B Tuschen-Caffier… - Scientific reports, 2021 - nature.com
Open-label placebos (OLPs) are placebos without deception in the sense that patients know
that they are receiving a placebo. The objective of our study is to systematically review and …
that they are receiving a placebo. The objective of our study is to systematically review and …
[PDF][PDF] Placebo effects in medicine
TJ Kaptchuk, FG Miller - N Engl J Med, 2015 - programinplacebostudies.org
Placebo effects are often considered the effects of an “inert substance,” but that
characterization is misleading. In a broad sense, placebo effects are improvements in …
characterization is misleading. In a broad sense, placebo effects are improvements in …
The evidence‐based group‐level symptom‐reduction model as the organizing principle for mental health care: time for change?
J van Os, S Guloksuz, TW Vijn… - World …, 2019 - Wiley Online Library
The content and organization of mental health care have been heavily influenced by the
view that mental difficulties come as diagnosable disorders that can be treated by specialist …
view that mental difficulties come as diagnosable disorders that can be treated by specialist …
The placebo effect in pain therapies
L Colloca - Annual review of pharmacology and toxicology, 2019 - annualreviews.org
Pharmacological strategies for pain management have primarily focused on dampening
ascending neurotransmission and on opioid receptor–mediated therapies. Little is known …
ascending neurotransmission and on opioid receptor–mediated therapies. Little is known …